_________________
December 7, 2023 | Acumen Analytics, a leader in intelligent digital transformation, have partnered to provide advanced risk management solutions for life sciences companies.
ValGenesis digital validation platform was chosen to enhance their global validation processes, underscoring its commitment to elevating CAR-T therapy production standards.
ValGenesis will provide technology transfer services and streamline multiple processes at the company’s manufacturing site in Brazil that produces a high-volume commercial product.
ValGenesis VLMS product suite alongside Soluciones GXP’s immense regulatory expertise across the life sciences sector in Latin America (LATAM).
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a UK-based global full-service contract research organization (CRO), selected ValGenesis VLMS to digitize its corporate validation process.
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a US government contractor selected ValGenesis VLMS to digitize its corporate validation process.
Canadian biotechnology company selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize its corporate validation process.
ValGenesis University marks a significant milestone in our unwavering commitment to customer success, enhancing the value of our customers' investments.
ValGenesis successfully concluded its annual user conference on Thursday, September 28th, having presented an impressive series of product innovations for 2024 to customers, partners, and industry experts.
Brevitas serves global leaders in the pharmaceutical, biopharmaceutical, biotechnology, medical devices, chemical, and food and beverage industries since 2010.